Literature DB >> 19308900

Biological variation in tests of hemostasis.

Giuseppe Banfi1, Massimo Del Fabbro.   

Abstract

The two components of biological variability are interindividual variability, which is the variability due to the heterogeneity of physiologic influences among subjects, and intraindividual variability, which is due to the variability in the same individual over time. Analysis of biological variation is crucial for estimating the critical difference, which corresponds with a threshold suggestive of a statistically significant difference between two consecutive results of a laboratory parameter in the same subject and is therefore unlikely attributable to casual (random) oscillation of values. Studies on biological variation of tests of hemostasis are outdated, and the published results should be confirmed by using modern, fully automated methods. Biological variation for coagulation screening tests (prothrombin time and activated partial thromboplastin time) is low and comparable with the values registered for hematologic parameters. However, the index of individuality (ratio between intraindividual and interindividual variability) suggests that the usual preoperative screening for coagulation disorders is influenced by the between-subjects variability. Thrombin time is very constant within and between subjects. Proteins such as fibrinogen, clotting factors, and antithrombin show a low biological variability. In contrast, fibrinolytic parameters, such as plasminogen activator inhibitor 1 and fibrinopeptide A, show very high variability, and their interpretation in the clinical setting must take this into consideration.

Entities:  

Mesh:

Year:  2009        PMID: 19308900     DOI: 10.1055/s-0029-1214155

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  4 in total

1.  Differential impacts of hemolysis on coagulation parameters of blood samples: A STROBE-compliant article.

Authors:  Lin-Lin Pan; Ching-Hui Lee; Kuo-Chuan Hung; I-Ting Tsai; Ming-Chung Wang; Cheuk-Kwan Sun
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

2.  Elevated plasma levels of plasminogen activator inhibitor-1 are associated with risk of future incident venous thromboembolism.

Authors:  Tobias Frischmuth; Kristian Hindberg; Pål Aukrust; Thor Ueland; Sigrid K Braekkan; John-Bjarne Hansen; Vânia M Morelli
Journal:  J Thromb Haemost       Date:  2022-03-25       Impact factor: 16.036

3.  Variability between laboratories performing coagulation tests with identical platforms: a nationwide evaluation study.

Authors:  Michael Nagler; Lucas M Bachmann; Lorenzo Alberio; Anne Angelillo-Scherrer; Lars M Asmis; Wolfgang Korte; Adriana Mendez; Guido Reber; Hans Stricker; Dimitrios A Tsakiris; Walter A Wuillemin
Journal:  Thromb J       Date:  2013-03-07

4.  Biological variations of ADAMTS13 and von Willebrand factor in human adults.

Authors:  Meltem Kilercik; Abdurrahman Coskun; Mustafa Serteser; Deniz Inan; Ibrahim Unsal
Journal:  Biochem Med (Zagreb)       Date:  2014-02-15       Impact factor: 2.313

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.